Public Health Trace

Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,326

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,859

Class I recallsReasonable probability of serious health consequences

24,440

Class II recallsTemporary or medically reversible health consequences

2,900

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,095 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/winco-foods-llc-issues-allergy-alert-undeclared-sesame-hoagie-rollsPublished October 22, 2026

Most affected stateHawaii 200 recalls mention this state

State: LA ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 24, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

Recalls by class
Class	Recalls
Class II	24,440
Class I	9,859
Class III	2,900
Not Yet Classified	2

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Betadine (povidone-iodine), Sterile Ophthalmic Solution, Preservative Free, 5% 0.5mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 656 Hercules Dr., Colchester, VT 05446, NDC 05446-1680-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/ Ketorolac Sterile Ophthalmic Solution, 10%/ 0.25%/ 0.25%/0.125%, 10 mL per dropper, Multiple Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, NDC 05446-0859-03

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl/Tropicamide/Cyclopentolate HCl/Ketorolac Sterile Ophthalmic Solution, 2.5%/0.25%/0.25%/0.125%, 0.5 mL syringe, Single Use Syringe, For Topical Ophthalmic Use, NDC 05446-0993-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl/Tropicamide, Sterile Ophthalmic Solution, 2.5%/1%, 15 mL per dropper, Multiple Dose Droptainer for Topical Ophthalmic Use, Edge Pharma, LLC, 856 Colchester, VT 05446, NDC 05446-0815-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl/Lidocaine, Sterile Ophthalmic Solution for Injection, Preservative Free, 1.5%/1%, 0.8mL per syringe, Single Use Syringe For Intraocular Injection, Edge Pharma LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1118-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preservative Free), Rx Only, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT NDC 05446-1667-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl, Sterile Solution for Injection, (PF), 800 mcg/10mL (80 mcg/mL), Single Use Syringe for IV Injection, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1652-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl, 1mg/10mL (0.1mg/mL), 10 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446 NDC 05446-1544-10

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl 0.5 mg/5mL, (0.1 mg/mL), 5 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1545-05

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenylephrine HCl / Tropicamide / Ciprofloxcin / Ketorolac Sterile Ophthalmic Solution, 10%/1%/0.3%/0.125%, 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1270-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Phenol, Sterile Solution for Injection (PF), 6%, 5 mL per vial, Single Use Vial for Perineural Injection, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1476-05, packaged in vials.

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

MVASI, (bevacizumab-awwb), Sterile Ophthalmic Solution for Injection, 3.25mg/0.13mL (25 mg/mL) 0.13 mL per syringe, Dose: 1.25mg/0.05mL, Single Use Syringe For Intraocular Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1661-13

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Neostigmine methylsulfate, 5 mg/5mL (1 mg/mL), 5 mL per syringe, Single Use Syringe for IV or IM Injection, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1549-05

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Moxifloxacin, Sterile Ophthalmic Solution for Injection, Preservative Free, 0.8mg/0.8 mL (1mg/mL), 0.8 mL per syringe, Single Use Syringe, For Intraocular Injection, Edge Pharma, LL, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1050-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C, Sterile Ophthalmic Solution, Preservative Free, 0.16mg/0.8mL (0.2 mg/mL), 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1011-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C Sterile Ophthalmic Solution, Preservative Free, 0.32mg/0.8 mL (0.4mg/mL) 0.8 mL per syringe, Single Use Syringe, For Topical Ophthalmic Use, Edge Pharma LLC, 856 Hercules Dr. Colchester, VT 05446, NDC 05446-1009-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Mitomycin-C, 40mg/40mL (1mg/mL), 40 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1416-01

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Methotrexate, USP, Sterile Solution for Injection (PF), 125 mg/5mL (2mg/mL), 5 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1505-05

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe,(NDC 05446-1600-05), Kit includes; individual syringe: Methacholine Chloride,16 mg/mL (contains 48 mg) NDC 05446-1241-01; Methacholine Chloride 4 mg/mL (contains 12mg), NDC 05446-1246-01; Methacholine chloride 1mg/mL (contains 3 mg), NDC 05446-1247-01; Methacholine chloride 0.25mg/mL (contains 0.75mg), NDC 05446-1248-01; and Methacholine chloride 0.0625mg/mL NDC 05446-1249-01 Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 7, 2023Historical recordClass II

Lidocaine HCL / Bupivacaine HCL (contains Hyaluronidase 15 units/mL), Sterile Ophthalmic Solution for Injection (PF), 2%/0.375%, 8 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1548-18

by Edge Pharma, LLC

Reason: Lack of Assurance of Sterility
Published: February 2, 2022
Distribution: Nationwide

View recall →

Data last updated: October 24, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.